These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9814134)

  • 1. New breast cancer drug.
    Harv Womens Health Watch; 1998 Nov; 6(3):7. PubMed ID: 9814134
    [No Abstract]   [Full Text] [Related]  

  • 2. First MAb approved for treatment of metastatic breast cancer.
    Brenner TL; Adams VR
    J Am Pharm Assoc (Wash); 1999; 39(2):236-8. PubMed ID: 10079656
    [No Abstract]   [Full Text] [Related]  

  • 3. NICE approves trastuzumab for early stage breast cancer.
    Mayor S
    BMJ; 2006 Jun; 332(7555):1409. PubMed ID: 16777868
    [No Abstract]   [Full Text] [Related]  

  • 4. Oh, Canada: Public outcry pushed demand for trastuzumab for early-stage breast cancer.
    Smith M
    J Natl Cancer Inst; 2005 Sep; 97(18):1327. PubMed ID: 16174852
    [No Abstract]   [Full Text] [Related]  

  • 5. Roche responds to the 'Herceptin or deception' article.
    Petersen S
    N Z Med J; 2006 Jul; 119(1237):U2069; author reply U2069. PubMed ID: 16862210
    [No Abstract]   [Full Text] [Related]  

  • 6. Genentech's anticancer Mab expected by November.
    Robertson D
    Nat Biotechnol; 1998 Jul; 16(7):615. PubMed ID: 9661186
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal antibody approved for metastatic breast cancer.
    Oncology (Williston Park); 1998 Dec; 12(12):1727. PubMed ID: 9874846
    [No Abstract]   [Full Text] [Related]  

  • 8. When the evidence is weak, caution should be applied.
    Lancet Oncol; 2010 Sep; 11(9):805. PubMed ID: 20816369
    [No Abstract]   [Full Text] [Related]  

  • 9. Trastuzumab for early breast cancer.
    Stuart NS; Bishop J; Bale C
    Lancet; 2006 Jan; 367(9505):107-8. PubMed ID: 16413865
    [No Abstract]   [Full Text] [Related]  

  • 10. Lapatinib moves forward in inflammatory and early HER2-positive breast cancer trials.
    Tuma RS
    J Natl Cancer Inst; 2007 Mar; 99(5):348-9. PubMed ID: 17341725
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer drug offers dramatic results for some.
    Mayo Clin Health Lett; 2006 Mar; 24(3):4. PubMed ID: 16566074
    [No Abstract]   [Full Text] [Related]  

  • 12. Trastuzumab in breast cancer.
    Gounaris IG
    N Engl J Med; 2006 Feb; 354(6):640-4; author reply 640-4. PubMed ID: 16470950
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trastuzumab. Monoclonal antibody for the treatment of breast cancer].
    Heinzl S
    Med Monatsschr Pharm; 2000 Nov; 23(11):350-2. PubMed ID: 11103587
    [No Abstract]   [Full Text] [Related]  

  • 14. [Healing in sight?].
    Jackisch C
    Krankenpfl J; 2005; 43(4-6):137. PubMed ID: 16171079
    [No Abstract]   [Full Text] [Related]  

  • 15. Unusual problems in breast cancer and a rare lung cancer case. Case 1. Clinical complete response of breast cancer metastases after trastuzumab-based immunotherapy.
    Tonini G; Vincenzi B; Santini D; Avvisati G; La Cesa A; Baldi A
    J Clin Oncol; 2003 Jun; 21(11):2215-6. PubMed ID: 12775749
    [No Abstract]   [Full Text] [Related]  

  • 16. Brain metastases in patients receiving trastuzumab for breast cancer.
    Salmaggi A; Silvani A; Boiardi A
    Neurol Sci; 2007 Mar; 28(1):1. PubMed ID: 17385088
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant trastuzumab for breast cancer.
    Dent R; Clemons M
    BMJ; 2005 Nov; 331(7524):1035-6. PubMed ID: 16269471
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing trastuzumab-resistant breast cancer.
    Krop I
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):108-10. PubMed ID: 19367251
    [No Abstract]   [Full Text] [Related]  

  • 19. Comment on: incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab.
    Errante D; Bernardi D; Bianco A; Salvagno L
    Acta Oncol; 2007; 46(4):565-6. PubMed ID: 17497328
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient is to appeal High Court ruling on breast cancer drug.
    Dyer C
    BMJ; 2006 Feb; 332(7539):443. PubMed ID: 16497748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.